These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1707569)

  • 1. [Natural killer cells in the interferon therapy of cancer patients].
    Shparyk IaV; Bilynskiĭ BT; Shloma DV
    Vopr Onkol; 1991; 37(2):136-43. PubMed ID: 1707569
    [No Abstract]   [Full Text] [Related]  

  • 2. [Natural killers during the treatment of patients with solid tumors].
    Bilynskiĭ BT; Shparik IaV
    Vopr Onkol; 1990; 36(2):131-8. PubMed ID: 2180206
    [No Abstract]   [Full Text] [Related]  

  • 3. The natural killer cell-interferon system in human carcinoma--its relation to interferon cancer treatment trials.
    Ching NP; Ching CY; Jim EL; Loh KK; Oishi N; Yim DW
    Hawaii Med J; 1984 Oct; 43(10):368-72. PubMed ID: 6210268
    [No Abstract]   [Full Text] [Related]  

  • 4. Analyses and perspectives in cancer immunotherapy.
    Nguyen van Binh P; Duc HT
    Biomed Pharmacother; 2006 Nov; 60(9):621-8. PubMed ID: 16978826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medullasin enhances human natural killer cell activity by a mechanism other than the induction of interferons or interleukin-2.
    Aoki Y; Fukuchi K
    Jpn J Cancer Res; 1987 Jan; 78(1):68-73. PubMed ID: 2434455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of various interferons on the spontaneous cytotoxicity exerted by lymphocytes from normal and tumor-bearing patients.
    Lucero MA; Fridman WH; Provost MA; Billardon C; Pouillart P; Dumont J; Falcoff E
    Cancer Res; 1981 Jan; 41(1):294-9. PubMed ID: 6160906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulation by cancer chemotherapeutic agents and antineoplastic activity.
    Spreafico F; Mantovani A
    Pathobiol Annu; 1981; 11():177-95. PubMed ID: 6460217
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro interactions of purified cloned human interferons on NK cells: enhanced activation.
    Targan S; Stebbing N
    J Immunol; 1982 Sep; 129(3):934-5. PubMed ID: 6180004
    [No Abstract]   [Full Text] [Related]  

  • 9. Approaches to the immunological monitoring of cancer patients treated with natural or recombinant interferons.
    Herberman RB; Thurman GB
    J Biol Response Mod; 1983; 2(6):548-62. PubMed ID: 6198476
    [No Abstract]   [Full Text] [Related]  

  • 10. Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies.
    Fujii S
    Trends Immunol; 2008 May; 29(5):242-9. PubMed ID: 18372215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Principles of tumor immunology.
    Den Otter W
    Postepy Hig Med Dosw; 1988; 42(2):117-24. PubMed ID: 3075997
    [No Abstract]   [Full Text] [Related]  

  • 12. Effector immune mechanisms in cancer.
    Lotzová E
    Nat Immun Cell Growth Regul; 1985; 4(6):293-304. PubMed ID: 3911064
    [No Abstract]   [Full Text] [Related]  

  • 13. Natural killer cells and naturally occurring antibodies as representatives of natural tumor immunity.
    Ehrlich R; Witz IP
    Pathobiol Annu; 1982; 12():85-113. PubMed ID: 6186979
    [No Abstract]   [Full Text] [Related]  

  • 14. Absence of antitumor natural killer cell-mediated defense in the brain.
    Yamasaki T
    Surg Neurol; 2004 Mar; 61(3):227-8. PubMed ID: 14984990
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of different types of interferon on the natural cellular cytotoxicity of lung cancer patients].
    Avdeev GI; Viadro MM; Leĭkin IuD; Kuznetsov VP; Trakhtenberg AKh
    Eksp Onkol; 1986; 8(3):44-6. PubMed ID: 2424715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon therapy in cancer: from imaginon to interferon.
    Goldstein D; Laszlo J
    Cancer Res; 1986 Sep; 46(9):4315-29. PubMed ID: 2425950
    [No Abstract]   [Full Text] [Related]  

  • 17. Natural killer cells.
    Herberman RB
    Prog Clin Biol Res; 1989; 288():161-7. PubMed ID: 2470107
    [No Abstract]   [Full Text] [Related]  

  • 18. Modulation of natural killer cell-mediated cytotoxicity by partially purified and cloned interferon-alpha.
    Lotzová E; Savary CA; Gutterman JU; Hersh EM
    Cancer Res; 1982 Jun; 42(6):2480-8. PubMed ID: 6176319
    [No Abstract]   [Full Text] [Related]  

  • 19. [NK cells--their role and importance in antitumor resistance].
    Mircheva Zh
    Eksp Med Morfol; 1984; 23(2):99-104. PubMed ID: 6205848
    [No Abstract]   [Full Text] [Related]  

  • 20. [Natural cytotoxic cells (NK) and their role in the immunological control of neoplasms].
    Rupniewska ZM; Adamczyk MB
    Postepy Hig Med Dosw; 1981; 35(1):37-52. PubMed ID: 6174960
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.